IMMUNIC, INC. — Director's Dealing 2022

Jul 11, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2022-07-08

Reporting Person: Toernsen Monika Maria (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-07-08	Stock Option	$4.30	A	30000	Acquired	2032-07-08	Common Stock (30000)	Direct

Footnotes

F1: 10,000 of the options vest in monthly increments over a period of one year from the grant date, and 20,000 of the options vest in monthly increments over a period of three years from the grant date.